UK and South Korea sign MoU on promoting biological standardization

The UK’s National Institute of Biological Standards and Control (NIBSC) and the National Institute of Food and Drug Safety Evaluation (NIFDS) from the Republic of Korea have signed a memorandum of understanding (MoU) paving the way for closer cooperation on promoting and evolving standardization of biological medicines and diagnostics, and for maintaining excellence in technical expertise and knowledge.

Final signatures were added to the agreement during the first day of the annual Expert Committee on Biological Standardization (ECBS) conference in Switzerland, hosted by the World Health Organization – a major event in the field of global standardization of biological medicines, noted an announcement by the UK’s Medicines & Healthcare products Regulatory Agency (MHRA).

The agreement aims to promote biological standardization, for example through international collaborative studies, and to pursue areas of mutual benefit, from access to, optimization of processing and transport of material, to building regulatory competence by exchange of scientific experts and joint workshops.